Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bacteriostatic Normal Saline vs Lidocaine for Lumbar Medial Branch Block Anesthesia
NCT04495868Phase 4Completed
- Sponsor
- Emory University
- Start
- Jan 2021
- Primary completion
- Apr 2022
- Modality
- Injectable Hydrogels, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bacteriostatic sodium chloride 0.9% injection in chronic low back pain (CLBP) (2 arms), sponsored by Emory University. Primary endpoint: Needle Placement Pain at Day 1. Started Jan 2021; status: completed.
02
Drugs
bacteriostatic sodium chloride 0.9% injection
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT04495868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04495868.